Comparison of Progression Rate of Retinal Pigment Epithelium Loss in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Aflibercept

Figure 2

Yearly progression of RPE loss in the right eye of a patient with nAMD and intravitreal ranibizumab therapy.